Literature DB >> 33327530

Comprehensive Analysis Reveals Novel Interactions between Circulating MicroRNAs and Gut Microbiota Composition in Human Obesity.

Taís Silveira Assmann1, Amanda Cuevas-Sierra1, José Ignacio Riezu-Boj1,2,3, Fermín I Milagro1,2,3, J Alfredo Martínez1,2,3.   

Abstract

BACKGROUND: The determinants that mediate the interactions between microRNAs and the gut microbiome impacting on obesity are scarcely understood. Thus, the aim of this study was to investigate possible interactions between circulating microRNAs and gut microbiota composition in obesity.
METHOD: The sample comprised 78 subjects with obesity (cases, body mass index (BMI): 30-40 kg/m2) and 25 eutrophic individuals (controls, BMI ≤ 25 kg/m2). The expression of 96 microRNAs was investigated in plasma of all individuals using miRCURY LNA miRNA Custom PCR Panels. Bacterial DNA sequencing was performed following the Illumina 16S protocol. The FDR correction was used for multiple comparison analyses.
RESULTS: A total of 26 circulating microRNAs and 12 bacterial species were found differentially expressed between cases and controls. Interestingly, an interaction among three miRNAs (miR-130b-3p, miR-185-5p and miR-21-5p) with Bacteroides eggerthi and BMI levels was evidenced (r2 = 0.148, p = 0.004). Moreover, these microRNAs regulate genes that participate in metabolism-related pathways, including fatty acid degradation, insulin signaling and glycerolipid metabolism.
CONCLUSIONS: This study characterized an interaction between the abundance of 4 bacterial species and 14 circulating microRNAs in relation to obesity. Moreover, the current study also suggests that miRNAs may serve as a communication mechanism between the gut microbiome and human hosts.

Entities:  

Keywords:  BMI; Bacteroides eggerthi; gut microbiota; miRNA; obesity

Year:  2020        PMID: 33327530     DOI: 10.3390/ijms21249509

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  4 in total

Review 1.  Research progress of nanocarriers for gene therapy targeting abnormal glucose and lipid metabolism in tumors.

Authors:  Xianhu Zeng; Zhipeng Li; Chunrong Zhu; Lisa Xu; Yong Sun; Shangcong Han
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

Review 2.  Functional and Therapeutic Significance of Tumor-Associated Macrophages in Colorectal Cancer.

Authors:  Yitong Li; Zhenmei Chen; Jiahao Han; Xiaochen Ma; Xin Zheng; Jinhong Chen
Journal:  Front Oncol       Date:  2022-02-02       Impact factor: 6.244

3.  MicroRNA-mediated regulation of lipid metabolism in virus-infected Emiliania huxleyi.

Authors:  Enquan Zhang; Jingjing Gao; Zehua Wei; Jun Zeng; Jian Li; Guiling Li; Jingwen Liu
Journal:  ISME J       Date:  2022-07-22       Impact factor: 11.217

Review 4.  Holistic Integration of Omics Tools for Precision Nutrition in Health and Disease.

Authors:  Omar Ramos-Lopez; J Alfredo Martinez; Fermin I Milagro
Journal:  Nutrients       Date:  2022-09-30       Impact factor: 6.706

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.